This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
5yxu
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='5yxu' size='340' side='right' caption='[[5yxu]], [[Resolution|resolution]] 2.70Å' scene=''> | <StructureSection load='5yxu' size='340' side='right' caption='[[5yxu]], [[Resolution|resolution]] 2.70Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[5yxu]] is a 10 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5YXU OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5YXU FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[5yxu]] is a 10 chain structure with sequence from [http://en.wikipedia.org/wiki/9hepc 9hepc] and [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5YXU OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5YXU FirstGlance]. <br> |
| - | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5yxu FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5yxu OCA], [http://pdbe.org/5yxu PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5yxu RCSB], [http://www.ebi.ac.uk/pdbsum/5yxu PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5yxu ProSAT]</span></td></tr> | + | </td></tr><tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">HLA-A, HLAA ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> |
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5yxu FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5yxu OCA], [http://pdbe.org/5yxu PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5yxu RCSB], [http://www.ebi.ac.uk/pdbsum/5yxu PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5yxu ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
| Line 10: | Line 11: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| + | [[Category: Human]] | ||
[[Category: Yi, L]] | [[Category: Yi, L]] | ||
[[Category: Affinity enhanced tcr-phla complex]] | [[Category: Affinity enhanced tcr-phla complex]] | ||
[[Category: Immune system]] | [[Category: Immune system]] | ||
Current revision
an affinity enhanced T cell receptor in complex with HLA-A0201 restricted HCV NS3 peptide KLVALGINAV
| |||||||||||
